Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models ; volume:42 ; number:1 ; day:26 ; month:5 ; year:2023 ; pages:1-19 ; date:12.2023
Journal of experimental & clinical cancer research ; 42, Heft 1 (26.5.2023), 1-19, 12.2023

Creator: Rupert, Christofer
Dell’ Aversana, Carmela
Mosca, Laura
Montanaro, Vittorino
Arcaniolo, Davide
Sio, Marco De
Bilancio, Antonio
Altucci, Lucia
Palinski, Wulf
Pili, Roberto
Nigris, Filomena de

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13046-023-02713-1

URN: urn:nbn:de:101:1-2023102512474162242380

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rupert, Christofer
Dell’ Aversana, Carmela
Mosca, Laura
Montanaro, Vittorino
Arcaniolo, Davide
Sio, Marco De
Bilancio, Antonio
Altucci, Lucia
Palinski, Wulf
Pili, Roberto
Nigris, Filomena de
SpringerLink (Online service)

Other Objects (12)

Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

Targeting mitochondrial metabolism for precision medicine in cancer

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma

Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma

ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment

The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism

Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

Targeting mitochondrial metabolism for precision medicine in cancer

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma

Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma

ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment

The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism

Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

Targeting mitochondrial metabolism for precision medicine in cancer

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma

Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma

ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment

The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models

Show object

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

Targeting mitochondrial metabolism for precision medicine in cancer

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma

Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma

ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment

The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism

Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

Targeting mitochondrial metabolism for precision medicine in cancer

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma

Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma

ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment

The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism

Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease

Targeting mitochondrial metabolism for precision medicine in cancer

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy

Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors

Strategic disruption of cancer’s powerhouse: precise nanomedicine targeting of mitochondrial metabolism

Targeting mitochondrial metabolism by the mitotoxin bromoxib in leukemia and lymphoma cells

PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma

Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma

ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism

Preclinical evaluation of Mito-LND, a targeting mitochondrial metabolism inhibitor, for glioblastoma treatment

The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism

Related objects

Reset password